MMR Vaccination

The MMR vaccine is recommended for individuals in many countries worldwide, as part of routine childhood immunisation programs and for certain adult populations.

While specific recommendations may vary slightly between countries based on factors such as disease prevalence and vaccination strategies, the general consensus among health authorities is to promote MMR vaccination as a standard preventive measure against measles, mumps, and rubella.

Children
The MMR vaccine is typically administered to children in two doses: the first dose at around 12-15 months of age and the second dose at 4-6 years of age.

Adults
Adults who have not previously received the MMR vaccine and lack evidence of immunity to measles, mumps, and rubella should also consider vaccination, particularly if they are at increased risk of exposure due to travel or occupation.

Travellers
Individuals traveling internationally, especially to regions experiencing measles outbreaks or where mumps and rubella are still prevalent, should ensure they are vaccinated against MMR before departure.

Measles Outbreaks
Measles outbreaks can occur when vaccination rates drop, leading to increased transmission within communities. Measles can cause severe complications, including pneumonia, encephalitis (inflammation of the brain), and death, particularly in young children and immunocompromised individuals.

Mumps Complications
Mumps can lead to complications such as orchitis (inflammation of the testicles) in males, which can cause infertility, as well as meningitis and deafness.

Rubella During Pregnancy
Rubella infection during pregnancy can result in congenital rubella syndrome, leading to serious birth defects and developmental disabilities in the newborn.

First Dose
Administered at around 12-15 months of age.

Second Dose
Administered at 4-6 years of age, before starting school. This second dose ensures long-lasting immunity and further boosts protection against measles, mumps, and rubella.

For adults who have not previously received the MMR vaccine or lack evidence of immunity, a two-dose series may also be recommended, with the doses administered at least 28 days apart.